Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
暂无分享,去创建一个
Yingli Lu | Yuetian Yu | Yi Chen | Ningjian Wang | Yuying Wang | Yue-yi Yu | Bin Wang
[1] K. Chayama,et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 , 2021, Journal of Gastroenterology.
[2] H. Tilg,et al. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals , 2020, Gut.
[3] C. Willer,et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. , 2020, Journal of hepatology.
[4] Z. Pang,et al. Famine Exposure in Early Life and Risk of Metabolic Syndrome in Adulthood: Comparisons of Different Metabolic Syndrome Definitions , 2019, Journal of diabetes research.
[5] H. Tilg,et al. Gut Dysfunction and Non-alcoholic Fatty Liver Disease , 2019, Front. Endocrinol..
[6] M. Stepanova,et al. Epidemiology of chronic liver diseases in the USA in the past three decades , 2019, Gut.
[7] Tom R. Gaunt,et al. Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study , 2019, Diabetes.
[8] B. Cha,et al. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis , 2018, Diabetes & metabolism journal.
[9] E. Bonora,et al. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis , 2018, Diabetes Care.
[10] A. Lonardo,et al. Nonalcoholic fatty liver disease: Evolving paradigms , 2017, World journal of gastroenterology.
[11] H. Te,et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States , 2017, PloS one.
[12] A. McCullough,et al. Natural History of Nonalcoholic Fatty Liver Disease , 2016, Digestive Diseases and Sciences.
[13] M. Jensen,et al. Is Exposure to Famine in Childhood and Economic Development in Adulthood Associated With Diabetes? , 2015, The Journal of clinical endocrinology and metabolism.
[14] M. Carstensen,et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. , 2015, Cell metabolism.
[15] C. Byrne,et al. NAFLD: a multisystem disease. , 2015, Journal of hepatology.
[16] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[17] Jimmy D Bell,et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. , 2014, European journal of endocrinology.
[18] Matthias Blüher,et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. , 2014, Cell metabolism.
[19] A. Canbay,et al. Extrahepatic complications of nonalcoholic fatty liver disease , 2014, Hepatology.
[20] S. Wild,et al. Resolution of fatty liver and risk of incident diabetes. , 2013, The Journal of clinical endocrinology and metabolism.
[21] P. Edwards,et al. Pleiotropic roles of bile acids in metabolism. , 2013, Cell metabolism.
[22] S. Friedman,et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid‐induced liver injury in superobese patients with nonalcoholic steatohepatitis , 2013, Hepatology.
[23] S. Wild,et al. Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes , 2012, Diabetes Care.
[24] P. O S I T I O N S T A T E M E N T. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[25] S. Summers,et al. Ceramides as modulators of cellular and whole-body metabolism. , 2011, The Journal of clinical investigation.
[26] V. Basevi. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[27] T. Joh,et al. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup , 2010, Journal of gastroenterology and hepatology.
[28] J Wouter Jukema,et al. Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach. , 2009, The Journal of clinical endocrinology and metabolism.
[29] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[30] F. Schmidt. Meta-Analysis , 2008 .
[31] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[32] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[33] G. McCaughan,et al. Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. , 2018, Advances in experimental medicine and biology.
[34] L. Henry,et al. NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .
[35] S. Summers,et al. CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance. , 2014, Cell metabolism.
[36] P. Macfarlane,et al. Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. , 2009, Endocrine reviews.
[37] Diagnosis and Classification of Diabetes Mellitus , 2003 .